Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614783 · ClinicalTrials.gov registry record
Screening for Early Evidence of Diabetes
A clinical trial, sponsored by VeraLight.
- Completed
- Registry status
- 3,478
- Enrollment target
NCT00614783: Completed study, sponsored by VeraLight.
NCT00614783 is a clinical trial that has completed, run by VeraLight. The registered enrollment target is 3,478 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00614783 has completed, sponsored by VeraLight.
- COMPLETED
- Registry status
- 3,478 participants
- Enrollment target
Study Summary
This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasive, light-based technology to measure the concentration of chemicals in the skin called advanced glycation endproducts (AGEs). Several studies have demonstrated that AGEs accumulate in skin faster in individuals with poor control of blood sugar. Persons will be eligible for the study if they are 'at risk' for diabetes based on their age and other risk factors as defined by the American Diabetes Association.
Primary Outcome
Relative true positive and false positive fractions between Scout (Visit 2, nonfasting) and FPG (Visit 1, fasting) for detecting abnormal glucose tolerance, using the 2 hr OGTT ≥ 140 mg/dL as the threshold for a positive result.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,478 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-12 |
What the finished NCT00614783 record still lists
NCT00614783 is an observational study that tracks outcomes without assigning an intervention. Its 3,478 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00614783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00614783 about?
NCT00614783 is a clinical study titled "Screening for Early Evidence of Diabetes". This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasi...
What is the current status of trial NCT00614783?
This trial is currently completed. The enrollment target is 3,478 participants. The study started on 2007-05. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00614783?
This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia